stockrowGilead Sciences, Inc.
GILD Healthcare Drug Manufacturers General
Gilead Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $29.4 billion, up 2.40% from fiscal 2024.
- Revenue
- +6.83%
- EPS
- −20.3%
- Free cash flow
- +21.1%
- Total debt
- +5.17%
Quarter to September 2026, against a year earlier
Follow GILD
Alert me
Gilead Sciences, Inc. (GILD) Operating margin
Gilead Sciences, Inc.'s operating margin over the twelve months to 30 September 2026 was −7.63%, down 41.7 percentage points from fiscal 2025 (34.0%). Over the past ten years it has ranged from 5.78% (fiscal 2024) to 68.0% (fiscal 2015); the current reading is higher than 55% of that period. That is below the Drug Manufacturers General industry median of 18.3% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 34.0% | 28.26 |
| FY2024 | 5.78% | (22.27) |
| FY2023 | 28.1% | 1.18 |
| FY2022 | 26.9% | (9.45) |
| FY2021 | 36.3% | 19.83 |
| FY2020 | 16.5% | (2.61) |
| FY2019 | 19.1% | (17.96) |
| FY2018 | 37.1% | (17.04) |
| FY2017 | 54.1% | (3.92) |
| FY2016 | 58.0% | (9.98) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 41.7% | 174.92 |
| Jun 2026 | −133.2% | (170.35) |
| Mar 2026 | 37.1% | 12.11 |
| Dec 2025 | 25.0% | (17.79) |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVO Novo Nordisk A/S compare | 43.4% |
| AMGN Amgen Inc. compare | 32.4% |
| NVS Novartis AG compare | 25.2% |
| AZN AstraZeneca PLC compare | 23.7% |
| BMY Bristol Myers Squibb Company compare | 22.7% |
| PFE Pfizer Inc. compare | 21.4% |
| SNY Sanofi compare | 18.7% |
| MRK Merck & Co., Inc. compare | 9.20% |
| GILD Gilead Sciences, Inc. | −7.63% |
| Drug Manufacturers General industry median | 18.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on GILD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement